Understanding the structural and functional implications of lysine succinylation in Mycobacterium tuberculosis heat

Subhashree Barik1, Kunal Shivaji Aldar2, Ayon Chakraborty3

  • 1School of Basic Sciences, Indian Institute of Technology Bhubaneswar, Bhubaneswar 752050, India.

Insights

Succinylating Mycobacterium tuberculosis Hsp16.3 alters its structure and stability, yet enhances its molecular chaperone activity. This modification offers potential therapeutic strategies against tuberculosis.

Area of Science:

  • Biochemistry and Molecular Biology
  • Tuberculosis Pathogenesis
  • Post-Translational Modifications

Background:

  • Heat shock protein 16.3 (Hsp16.3) is a key antigen in Mycobacterium tuberculosis, crucial for pathogen survival and BCG vaccine efficacy.
  • Proteomic studies identified extensive lysine succinylation on Hsp16.3 in vivo, but its functional consequences were unknown.

Purpose of the Study:

  • To investigate the structural, stability, and functional effects of Hsp16.3 succinylation.
  • To explore the impact of succinylation on Hsp16.3's molecular chaperone activity.

Main Methods:

  • In vitro succinylation using physiological and non-physiological donors.
  • Structural analysis via circular dichroism (CD) and fluorescence spectroscopy.
  • Mass spectrometry and fluorescamine assay for succinylation confirmation.
  • Stability assessment using urea-denaturation and chymotrypsin digestion.
  • In-silico computational studies.

Main Results:

  • Succinylating all eight lysine residues induced significant secondary and tertiary structural changes.
  • Succyinylation led to oligomeric dissociation (dodecamer to dimer) and increased surface hydrophobicity.
  • Protein stability was reduced, increasing conformational flexibility, but chaperone activity was enhanced.

Conclusions:

  • Lysine succinylation profoundly impacts Hsp16.3 structure, stability, and chaperone function.
  • Enhanced chaperone activity despite reduced stability suggests a complex regulatory role for succinylation.
  • Targeting Hsp16.3 succinylation presents a potential therapeutic strategy for M. tuberculosis infections.